Dublin, Sept. 05, 2024 (GLOBE NEWSWIRE) — The “Meningococcal Vaccines – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.
The global market for Meningococcal Vaccines is estimated at US$3.5 Billion in 2023 and is projected to reach US$4.9 Billion by 2030, growing at a CAGR of 4.8% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The report provides comprehensive insights into the global Meningococcal Vaccines market, highlighting the significant growth potential of the Quadrivalent Meningococcal Vaccines segment, which is expected to reach US$2.8 billion by 2030 with a CAGR of 5.1%. Additionally, the Bivalent Meningococcal Vaccines segment is forecasted to grow at a 4.6% CAGR over the next seven years. The report offers a detailed regional analysis, with particular emphasis on the U.S. market, estimated at $1.1 billion in 2023, and China, which is projected to grow at a 4.5% CAGR to reach $849.7 million by 2030. Other key regions, including Japan, Canada, Germany, and the Asia-Pacific, are also analyzed for growth trends.
The report features comprehensive market data, including independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030. In-depth regional analysis covers key markets worldwide, offering valuable insights into regional dynamics. The report also includes profiles of major companies, such as Baxter International, Inc., Bio-Med Pvt., Ltd., and GlaxoSmithKline PLC, providing insights into their market presence across different geographies.
Purchasing this report will offer access to detailed market analysis, competitive insights, and future trends, empowering you with actionable insights to identify new revenue opportunities and make informed strategic business decisions. Additionally, the report offers complimentary updates for one year to keep you abreast of the latest market developments.
Key Questions Answered:
- How is the Global Meningococcal Vaccines Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 194 |
| Forecast Period | 2023 – 2030 |
| Estimated Market Value (USD) in 2023 | $3.5 Billion |
| Forecasted Market Value (USD) by 2030 | $4.9 Billion |
| Compound Annual Growth Rate | 4.8% |
| Regions Covered | Global |
Key Topics Covered:
MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Global Economic Update
- Meningococcal Vaccines – Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
FOCUS ON SELECT PLAYERS(Total 42 Featured):
- Baxter International, Inc.
- Bio-Med Pvt., Ltd.
- GlaxoSmithKline PLC
- Pfizer, Inc.
- Sanofi SA
- Serum Institute of India Pvt., Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/6r68cb
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Meningococcal Vaccines Market
